Skip to main content
Contact Us
Subscribe
E-Edition
53°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
2025 Calendar Photos
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Collplant Biotechnologies Ltd ADR
(NQ:
CLGN
)
4.140
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
4.140
Bid (Size)
3.300 (3)
Ask (Size)
5.000 (4)
Prev. Close
4.140
Today's Range
4.140 - 4.140
52wk Range
3.310 - 6.980
Shares Outstanding
10,258,129
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Cracking The Code: Understanding Analyst Reviews For CollPlant Biotechnologies
August 21, 2024
Via
Benzinga
CLGN Stock Earnings: CollPlant Biotechnologies Beats EPS, Misses Revenue for Q2 2024
August 20, 2024
CLGN stock results show that CollPlant Biotechnologies beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.
Via
InvestorPlace
Performance
YTD
-31.57%
-31.57%
1 Month
+4.22%
+4.22%
3 Month
-18.82%
-18.82%
6 Month
-30.42%
-30.42%
1 Year
-26.73%
-26.73%
More News
Read More
CLGN Stock Earnings: CollPlant Biotechnologies Meets EPS, Misses Revenue for Q1 2024
May 29, 2024
Via
InvestorPlace
CLGN Stock Earnings: CollPlant Biotechnologies Misses EPS, Misses Revenue for Q4 2023
April 04, 2024
Via
InvestorPlace
Earnings Scheduled For April 4, 2024
April 04, 2024
Via
Benzinga
Recap: CollPlant Biotechnologies Q3 Earnings
November 29, 2023
Via
Benzinga
Earnings Outlook For CollPlant Biotechnologies
November 28, 2023
Via
Benzinga
Preview: CollPlant Biotechnologies's Earnings
August 23, 2023
Via
Benzinga
CollPlant Biotechnologies: Q1 Earnings Insights
May 24, 2023
Via
Benzinga
Earnings Scheduled For November 29, 2023
November 29, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
October 19, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
August 24, 2023
Via
Benzinga
Earnings Preview: CollPlant Biotechnologies
May 23, 2023
Via
Benzinga
Earnings Outlook For CollPlant Biotechnologies
March 28, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
July 25, 2023
Via
Benzinga
Why Carnival Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session
June 26, 2023
Via
Benzinga
Why CollPlant Biotechnologies Stock Is Trading Higher
June 26, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
June 26, 2023
Via
Benzinga
Earnings Scheduled For May 24, 2023
May 24, 2023
Via
Benzinga
Stratasys and CollPlant Unite Technologies to Transform Healthcare with Industrial-Scale Bioprinting of Tissues and Organs
April 04, 2023
From
Stratasys Ltd.
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For February 17, 2023
February 17, 2023
Via
Benzinga
Top 5 Health Care Stocks That May Dip
January 27, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
December 05, 2022
Via
Benzinga
CollPlant Biotechnologies: Q2 Earnings Insights
August 25, 2022
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
July 21, 2022
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.